Former Illumina Senior Director Dr. Fan Jianbing Joins Chinese IVD Firm Kangsheng Global as Chief Scientific Officer Amid Hong Kong IPO Filing

Dr. Fan is the founder of Guangzhou Benchmark Medical Co., Ltd. ("Benchmark Medical").Before founding AnchorDx, Dr. Fan served as the Senior Technical Director of Illumina, Inc. As a core R&D member of Illumina's early gene chip technology, Dr. Fan led his team to successfully develop a series of products that have been widely applied in various critical fields such as genomics, genotyping, gene expression, and DNA methylation.Before joining Illumina, Dr. Fan worked at Affymetrix, Inc., then a giant in the gene chip industry, where he led a team in developing research application products for large-scale genomic genotyping.

Professor Huang Shiang, the founder and CEO of our company, stated:"We are delighted to collaborate with Dr. Fan. As an expert in the field of human genetics, Dr. Fan has 30 years of experience in human genomics, gene chip, and high-throughput sequencing technology development. We look forward to Dr. Fan and his team’s unique expertise in the early screening and diagnosis of cancer continuing to lead the way for基准医疗 (Benchmark Medical) and making a significant impact on the promising platform of康圣环球 (KingMed Global)."

Dr. Jianbing Fan said:"I am deeply honored to join KingMed Diagnostics and contribute to the development of a 'comprehensive, systematic, and advanced' specialized testing platform for the group. I will work alongside the group's existing outstanding research team to advance the research, development, and translation of early cancer screening and diagnosis products, bringing more patients the hope and turning point for life."

To facilitate communication and exchange among the readers and fans of the In Vitro Diagnostics Network, we have specially established the 156th In Vitro Diagnostics Network group in China! Everyone is welcome to scan the QR code below to join the group and participate actively in discussions!